Leukemia Clinical Trials in Philadelphia

Showing 661-680 of 1,308 trials

IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles

NCT02627092

The purpose of this study is to assess the impact of copper linens on hospital acquired infections and drug resistant bacteria.

Critically Ill

University of Pennsylvania585 participantsStarted Jan 2016

Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 1/2< 1 mile

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

NCT03123783

This study is a Phase 1-2 open-label dose escalation study of the immuno-activating monoclonal antibody APX005M administered in combination with nivolumab to adult subjects with non-small cell lung cancer or metastatic melanoma. The Phase 1 portion is intended to establish the maximum tolerated dose and the recommended phase 2 dose of APX005M when administered in combination with nivolumab. The Phase 2 portion of the study will evaluate safety and efficacy of the combination.

CancerNon Small Cell Lung Cancer MetastaticMetastatic Melanoma+2 more

Apexigen America, Inc.140 participantsStarted Jul 2017

Tucson, Arizona, United States • Duarte, California, United States • New Haven, Connecticut, United States +20 more locations

IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

Leukemia Trials in Other Cities

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.

Prospective Clinicogenomic Program

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Mite Asthma Pediatric Immunotherapy Trial

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab

Survival Prolongation by Rationale Innovative Genomics

International Lung Screen Trial (ILST)

Other Conditions in Philadelphia